Impaired glucose metabolism in hypertensive patients with/without the metabolic syndrome

European Journal of Internal Medicine

Volumn 25, Issue 5, 2014, Pages 477-481

  Carnevale Schianca, Gian Piero ^a   Fra, Gian Paolo ^a   Steffanini, Mara ^a,b   Pogliani, Gabriele ^a,b   Marconi, Cecilia ^a,b   Bigliocca, Marcello ^a,b   Pirisi, Mario ^a,b  

^a Azienda Ospedaliera Universitaria Maggiore Della Carita   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Cardiovascular risk; Hypertension; Impaired glucose metabolism; Metabolic syndrome; OGTT

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DIABETES MELLITUS; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; SMOKING; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; PREDIABETIC STATE; PREVALENCE; RETROSPECTIVE STUDY;

BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDIABETIC STATE; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84901631621     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2014.04.006     Document Type: Article

References (38)

1. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, and G. Germano et al. 2007 Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 2007 1105 1187
2. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
3. S.M. Grundy, H.B. Brewer Jr., J.I. Cleeman, S.C. Smith Jr., and C. Lenfant Definition of metabolic syndrome: report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issue related to definition Circulation 109 2004 433 438
4. S. Genuth, K.G. Alberti, P. Bennett, J. Buse, R. Defronzo, and R. Kahn et al. The Expert Committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 2003 3160 3167
5. The DECODE-study group, and European Diabetes Epidemiology Group Diabetes Epidemiology: collaborative analysis of diagnostic criteria in Europe. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies Diabetologia 42 1999 647 654
6. F. Vegt, J.M. Dekker, A. Jager, E. Hienkens, P.J. Kostense, and C.D.A. Stehouwer Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study JAMA 285 2001 2109 2113
7. S. Mottillo, K.B. Filion, J. Genest, L. Joseph, L. Pilote, and P. Porier et al. The metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis J Am Coll Cardiol 56 2010 1113 1132
8. J.H. Fuller, M.J. Shipley, G. Rose, R.J. Jarret, and H. Keen Mortality from coronary disease and stroke in relation to degree of glycaemia: the Whitehall Study BMJ 287 1983 867 870
9. DECODE Study Group, and the European Diabetes Epidemiology Group Glucose tolerance and cardiovascular mortality. Comparison of fasting and 2-hour diagnostic criteria Arch Intern Med 16 2001 397 404
10. P. Korhonen, P. Aarnio, T. Saarestranta, T. Saarestranta, P. Jaatinen, and I. Kantola Glucose homeostasis in hypertensive subjects Hypertension 51 2008 945 949
11. A.M. Salmasi, A. Alimo, and M. Dancy Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic Am J Hypertens 17 2004 483 488
12. S. Lüders, F. Hammersen, A. Kulschewski, U. Venneklaas, C. Züchner, and A. Gansz Diagnosis of impaired glucose tolerance in hypertensive patients in daily clinical practice Int J Clin Pract 59 2005 632 638
13. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, and K.A. Donato et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
14. C. Lorenzo, K. Williams, K.J. Unt, and S.M. Haffner The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes Diabetes Care 30 2007 8 13
15. G. Schillaci, M. Pirro, G. Vaudo, F. Gemelli, S. Marchesi, and C. Porcellati et al. Prognostic value of the Metabolic Syndrome in essential hypertension J Am Coll Cardiol 43 2004 1817 1822
16. A.O. Rantala, H. Kauma, M. Lilja, M.J. Savolainen, A. Reunanen, and Y.A. Kesaniemi Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects J Intern Med 245 1999 163 174
17. A.D. Sumner, G.L. Sardi, and J.F. Reed III Components of the metabolic syndrome differ between young and old adults in the US population J Clin Hypertens 14 2012 502 506
18. C.H. Su, C.Y. Fang, J.S. Chen, H.L. Po, L.P. Chou, and C.Y. Chiang et al. Prevalence of metabolic syndrome and its relationship with cardiovascular disease among hypertensive patients 55-80 years of age Acta Cardiol Sin 27 2011 229 237
19. J.B. Meigs, R.B. D'Agostino Sr., P.W. Wilson, L.A. Cupples, D.M. Nathan, and D.E. Singer Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study Diabetes 46 1997 1594 1600
20. L. Lind, C. Berne, and H. Lithell Prevalence of insulin resistance in essential hypertension J Hypertens 13 1995 1457 1462
21. S. Haffner, and H. Taegtmeyer Epidemic obesity and the metabolic syndrome Circulation 108 2003 1541 1545
22. T.W. Gress, F.J. Nieto, E. Shahar, M.R. Wofford, and F.R. Brancati Hypertension and antihypertensive therapy as a risk factor for type 2 diabetes mellitus. Atherosclerosis risk in communities study N Engl J Med 342 2000 905 912
23. B.M. Cheung, and C. Li Diabetes and hypertension: is there a common metabolic pathway? Curr Atheroscler Rep 14 2012 160 166
24. J.B. Meigs, D.M. Nathan, P.W. Wilson, L.A. Cupples, and D.E. Singer Metabolic risk factors worsen continuously across the spectrum of non-diabetic glucose tolerance. The Framingham Offspring Study Ann Intern Med 128 1998 524 533
25. W.J. Elliott, and P.M. Meyer Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis Lancet 369 2007 201 207 10.1016/S0140-6736(07)60108-1
26. M.H. Alderman New onset diabetes during antihypertensive therapy Am J Hypertens 21 2008 493 499 10.1038/ajh.2008.17
27. G. Tocci, F. Paneni, F. Palano, S. Sciarretta, A. Ferrucci, and T. Kurtz et al. Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials Am J Hypertens 24 2011 582 590
28. C.M. Alexander, P.B. Landsman, S.M. Teutsch, and S.M. Haffner NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older Diabetes 52 2003 1210 1214
29. E. Bartoli, G.P. Fra, and G.P. Carnevale Schianca The oral glucose tolerance test (OGTT) revisited Eur J Intern Med 22 2011 8 12
30. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 33 2010 S62 S69
31. E. Selvin, M.W. Steffes, H. Zhub, K. Matsushita, L. Wagenknecht, and J. Pankow et al. Glycated hemoglobin, diabetes and cardiovascular risk in nondiabetic adults N Engl J Med 362 2010 800 811
32. A.P. Carson, K. Reynolds, V.A. Fonseca, and P. Muntner Comparison of A1C and Fasting Glucose Criteria to Diagnose Diabetes Among U.S. Adults Diabetes Care 33 2010 95 99
33. E. Van't Riet, M. Alssema, J.M. Rijkelijkhuizen, P.J. Kostense, G. Nijpels, and J.M. Dekker Relationship Between A1C and Glucose Levels in the General Dutch Population: The New Hoorn Study Diabetes Care 33 2010 61 66
34. C.K. Kramer, M.R.G. Araneta, and E. Barrett-Connor A1C and Diabetes Diagnosis: The Rancho Bernardo Study Diabetes Care 33 2010 101 103
35. Z.X. Lu, K.Z. Walker, K. O'Dea, K.A. Sikaris, and J.E. Shaw A1C for screening and diagnosis of type 2 diabetes in routine clinical practice Diabetes Care 33 2010 817 819
36. P. Bougnères Genetics of obesity and type 2 diabetes. Tracking pathogenic traits during the predisease period Diabetes 51 2002 S295 S303
37. W. Kang, D.J. Kim, M.S. Lee, K.W. Kim, and M.K. Lee Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects Diabetes Res Clin Pract 69 2005 180 187
38. J. Segura, C. Roldán, J.A. Garciá-Donaire, and L.M. Ruilope Prediabetes and cardiovascular risk in hypertensive patients Curr Hypertens Rep 8 2006 97 100